What are dopamine agonists?

Dopamine agonists are a class of medications used to mimic the effects of dopamine, a neurotransmitter that plays a crucial role in movement and coordination. In Parkinson’s, dopamine-producing neurons in the brain progressively deteriorate. This leads to motor symptoms such as tremor, stiffness, and slowed movement. Dopamine agonists stimulate dopamine receptors, helping to alleviate these symptoms without directly replacing dopamine like levodopa-based treatments.

Dopamine agonists are often prescribed in the early stages of Parkinson’s or alongside levodopa to enhance symptom control and are an important pharmacotherapeutic agent. They can help:

  • Reduce motor fluctuations, particularly “off” periods when symptoms return between doses of levodopa.
  • Delay the need for levodopa, potentially postponing the onset of levodopa-induced dyskinesia (involuntary movements).
  • Provide longer-lasting symptom relief, as dopamine agonists remain active in the body for extended periods.
  • Dopamine agonists, such as ropinirole, are the first-line treatment for restless legs syndrome.

How are dopamine agonists used?

Dopamine agonists are available in various forms, including:

  • Tablets (e.g., pramipexole, ropinirole) taken orally. There are two tablet forms: immediate or extended-release tablets.
  • Skin patches (e.g., rotigotine) for continuous absorption.
  • Injectable formulations (e.g., apomorphine) for rapid symptom relief. Apomorphine is administered by subcutaneous injection.

Treatment typically starts with a low dose, gradually increasing to minimise side effects. Some patients may use dopamine agonists alone, while others combine them with levodopa therapy for enhanced symptom management.

 Benefits of dopamine agonists

  • Mimic dopamine activity, improving motor symptoms.
  • Longer duration of action compared to levodopa, reducing fluctuations.
  • Lower risk of dyskinesia when used early in treatment.
  • Available in multiple formulations, offering flexibility in treatment.

 Risks and side effects

Nausea, vomiting, orthostatic hypotension, headache, dizziness, and cardiac arrhythmia are the most common side effect of dopamine agonists. These adverse effects are mostly dosage-dependent. It is highly recommended to start these medications at a low dosage to reduce the risk of orthostatic hypotension. Serotonin receptor antagonist antiemetics should not be taken together as they may enhance the hypotensive effect of dopamine agonists. While effective, dopamine agonists can also cause the above side effects, including:

  • Nausea and vomiting, especially when starting treatment.
  • Low blood pressure, leading to dizziness or fainting.
  • Irresistible sleep attacks may occur in patients who are taking pramipexole and ropinirole. Symptoms such as increased sedation, yawning, drowsiness, somnolence, and daytime sleepiness have been observed with dopamine agonist use.
  • Hallucinations or confusion, particularly in older patients.
  • Impulse control disorders, such as compulsive gambling, shopping, or eating.

 Considerations before use 

Dopamine agonist use requires caution in patients with a medical history of hypertension, cardiovascular, renal, and hepatic disease. Dopamine agonists may not be suitable for people with:

  • Severe cognitive impairment, as they can worsen confusion.
  • Psychiatric conditions, due to potential mood changes.
  • Some formulations may affect blood pressure.
  • Contraindications to dopamine agonists include pregnancy and for nursing mothers, as these medications inhibit lactation.

References 

Choi J, Horner KA. Dopamine Agonists. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551686/

Parkinson’s Foundation. (2025). Dopamine agonists: Mechanisms and treatment considerations. Retrieved from https://www.parkinson.org/living-with-parkinsons/treatment/prescription-medications/dopamine-antagonists

Parkinson’s UK. (2025). Dopamine agonists: Uses, benefits, and side effects. Retrieved from https://www.parkinsons.org.uk/information-and-support/dopamine-agonists-pramipexole-ropinirole

Healthline. (2025). Dopamine agonists: Common uses, side effects, and more. Retrieved from https://www.healthline.com/health/parkinsons-disease/dopamine-agonist

Share

Other articles

  • CARERS | Changing roles

    Being a care partner for a loved one with Parkinson’s Caring for a loved one with Parkinson’s is a journey that often redefines your role in the relationship. As Parkinson’s progresses, you may find yourself shifting from being a parent, partner, spouse, sibling or child to taking on responsibilities as both a carer and a [...]

  • MEDICATIONS | Understanding Parkinson’s medications

    There’s no standard roadmap for Parkinson’s medications. Treatments are tailored to your symptoms and needs, which may change over time. While Levodopa is often the first choice, other medications may be added as symptoms evolve. Don't be afraid to tell your neurologist you don't think things are working or that your most bothersome symptoms have changed and get treated for those to maintain your quality of life. The one thing that’s certain, flexibility is key in managing medications as your symptoms and needs change.

  • MEDICATIONS | Dopamine agonists

    Dopamine agonists are a valuable treatment option for Parkinson’s, particularly in the early stages or alongside levodopa therapy. While they offer a range of delivery methods and long-lasting symptom relief, patients should be aware of potential side effects and risks. Consulting a neurologist or movement disorder specialist is essential to determine the most suitable treatment approach.